SecBot SecBot

INBP

INTEGRATED BIOPHARMA INC
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001016504 Biotech & Drug Discovery
$0.1800 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $0.1800
Next earnings
Nov 5
in 10 days
1 year
−41.9%
from $0.3100 · Oct 27
30 days
+5.9%
from $0.1700
52-week range
$0.1500–0.3800
−53% from high · low Jul 28
Avg volume 20D
17.2K
Sep 28 spike 111.4K
Short interest
4
0.0%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
Filing reports
5
analyzed by SecBot
SecBot read BEARISH 2 reports · 90 days
Balance 1 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/2 ·Next Earnings date, Nov 5, 2026
Strongest BEARISH Integrated BioPharma reported a severe Q4 and FY2026 earnings miss, with Q4 revenue falling 31.0% YoY to…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • Short sellersSTEADY

    Short interest 0.0% to 4 shares. 1.0 days to cover.

  • TrendUPTREND

    1% above its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 Earnings calendar
INBP Q4 2026 Earnings Scheduled — 2026-09-30
Sep 25, 2026 SEC
Integrated BioPharma reported a severe Q4 and FY2026 earnings miss, with Q4 revenue falling 31.0% YoY to $9.8M and a…
8-K — Impact 6/10
Aug 20, 2026 SEC
Integrated BioPharma's wholly-owned subsidiary Manhattan Drug Company appointed Michael Richtmyer as Head of…
8-K — Impact 2/10
Jul 2, 2026 SEC
Integrated BioPharma entered into an amendment with PNC Bank that extends its $4M revolving credit facility maturity…
8-K — Impact 3/10
Jun 24, 2026 Insider
Milmoe William H. was granted 50,000 shares
Director
Jun 24, 2026 Insider
Canarick Robert was granted 50,000 shares
Director
Jun 24, 2026 Insider
DeSantis Damon was granted 50,000 shares
Director

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jun 24, 2026
Milmoe William H.
Director
AWARD50,000 sh
Jun 24, 2026
Canarick Robert
Director
AWARD50,000 sh
Jun 24, 2026
DeSantis Damon
Director
AWARD50,000 sh
Jun 24, 2026
Friedman Eric J
Director
AWARD50,000 sh
Apr 15, 2026
DeSantis Damon
Director
GIFT8,966,547 sh
Apr 15, 2026
DESANTIS CARL
10%+ Owner
GIFT8,966,547 sh
Apr 15, 2026
Milmoe William H.
Director
GIFT8,966,547 sh
Apr 15, 2026
DESANTIS CARL
10%+ Owner
GIFT2,235,417 sh

Earnings setup

Estimates
Nov 5
reports in 10 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
4
shares short
0.0%
vs prior settlement
1.0
days to cover
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
INBP Q1 2027 Earnings Scheduled — 2026-11-05
Recent
Sep 30, 2026
Earnings date
INBP Q4 2026 Earnings Scheduled — 2026-09-30
May 7, 2026
Earnings date
INBP Q3 2026 Earnings Scheduled — 2026-05-07

SecBot reports

5 filings · 0 bullish · 2 bearish · 3 neutral
All INBP filing & press-release reports (5)